-
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: A Journey To Focus On Data And Digital
Apr 9, 2018, 11:49 AM by Michael CroftForbes | Novartis announced it would buy gene therapy pioneer AveXis for $8.7 billion, giving the Swiss drug giant several treatments for rare diseases that work by inserting new DNA into patients' cells.Full story -
ChargePoint Technology boosts US team to support regional growth
Apr 9, 2018, 11:36 AM by Michael Croft, N/A, UNITED STATES - Apr 9, 2018 - Powder containment and aseptic transfer valve specialist ChargePoint Technology, has appointed two new area managers to support the increased demand for its containment technologies and solutions throughout the USFull story -
Equus VP of Customer Solutions to Deliver a Keynote Address at IDeACOM 2018
Apr 6, 2018, 12:46 PM by Michael CroftEDINA, MN, UNITED STATES - Apr 6, 2018 - Equus Compute Solutions, the largest U.S. manufacturer of custom computer hardware systems to the channel, announces its Vice President of Customer Solutions Steve Grady will deliver a keynote address at IDeACOM 2018, taking place April 8-10 in Washington, DFull story -
This Company Can Encode Your Favorite Song In DNA—For $100,000
Apr 6, 2018, 11:04 AM by Michael CroftMIT Technology Review | It's not cheap. But Twist Bioscience thinks storing data in genes could be the next big thing.Full story -
First Annual Model-informed Drug Development Gran Prix Deemed a Success
Apr 5, 2018, 14:18 PM by Michael CroftPRINCETON, NJ - Apr 5, 2018 - Certara®, the global leader in model-informed drug development and regulatory science, and faculty at the UNC Eshelman School of Pharmacy today announced the winners of the first Model-informed Drug Development (MIDD) Gran PrixFull story -
Five Use Cases For AI and Machine Learning In Commercial Pharma
Apr 4, 2018, 09:00 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Over the last decade, early business uses of Artificial Intelligence (AI), or machine learning, in life sciences have proven successful in drug discovery – predicting molecule-target bonding, identifying new biomarkers, and uncovering new drug indications. Now machine learning is gaining broader traction into other areas, including commercial operations, and transforming the way the industry collects, synthesizes, and uses data.
-
Sekisui XenoTech Adds Fatty Liver Disease Tissue Arrays, Microsome Pool to Research Biobank
Apr 3, 2018, 09:41 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Apr 3, 2018 - Sekisui XenoTech now offers human liver tissue microarrays and a microsomal pool for studying and developing new treatments for fatty liver disease (FLD)Full story -
Kite Pharma Veterans Launching New Firm To Develop Off-The-Shelf CAR-T
Apr 3, 2018, 08:45 AM by Michael CroftSTAT | Two former Kite Pharma executives unveiled Allogene Therapeutics, a new company trying to develop a suite of CAR-T therapy assets designed so that they do not need to be personalized for each cancer patient.Full story -
Platypus: Deep Data Dives For Clinical Data Reviewer
Apr 2, 2018, 09:05 AM by Michael CroftFull storyBio-IT World | If you are creating a tool designed to give a sixth sense, of course you name it after a semiaquatic, egg-laying mammal endemic to eastern Australia. Not unlike the animal, Takeda’s Platypus is made up of various parts, specifically designed to meet the medical reviewer’s needs.
-
Neurocentrx appoints two industry heavyweights to Board
Apr 2, 2018, 05:17 AM by Michael Croft- Apr 2, 2018 - Neurocentrx, an Edinburgh-based pharmaceutical company, has appointed Nigel Brooksby as Non-Executive Chairman and DrFull story -
Deceptive Cloud Efficiency: Do You Really Pay As You Use?
Mar 30, 2018, 08:57 AM by Michael CroftForbes | Cloud computing is often described as a "pay as you go" service, but that might not really be the case.Full story -
Jennifer Doudna Joins Synthego Advisory Board
Mar 29, 2018, 14:10 PM by Michael CroftBio-IT World News Brief | Jennifer Doudna has joined Synthego’s advisory board. She will advise Synthego on a variety of product, partnership, and business strategy initiatives to help amplify the company's fast-growing impact in the genome engineering space. The advisory role builds on Doudna’s January 2017 individual investment in the company.Full story -
AI Designs Organic Syntheses
Mar 29, 2018, 12:59 PM by Michael CroftNature | Software that devises effective schemes for synthetic chemistry has depended on the input of rules from researchers. A system is now reported in which an artificial-intelligence program learns the rules for itself.Full story -
The Government Wants To Free Health Data. Will That Unleash Innovation?
Mar 29, 2018, 09:41 AM by Michael CroftSTAT | The Centers for Medicare and Medicaid Services wants to put patients in charge of their information - and it wants to do so explicitly to help app and device makers gain access to high-quality data.Full story -
Niche CDMO adds spray drying for highly potent drugs
Mar 28, 2018, 08:43 AM by Michael Croft- Mar 28, 2018 - IDIFARMA has announced new GMP spray drying capabilities which will make it one of the very few contract development and manufacturing organisations (CDMO) to offer spray drying technology for highly potent drugs up to Category 4 OEL/OEBFull story -
PAREXEL, Vanderbilt University, Boehringer Ingelheim, And More: News From March 2018
Mar 28, 2018, 07:45 AM by Michael CroftFull storyBio-IT World | March featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including PAREXEL, Vanderbilt University, Boehringer Ingelheim, and more.
-
CRISPR Restored: Scientists Reverse Finding That Gene Editing Technology Had Flaws
Mar 27, 2018, 13:54 PM by Michael CroftForbes | Last summer a paper appeared suggesting that CRISPR gene editing could cause hundreds of off-target mutations. Turns out that was wrong, and the authors have just published a preprint admitting it.Full story -
BioIVT Acquires Ascendance Biotechnology, Expanding its Drug Safety Testing and Toxicology Portfolios
Mar 27, 2018, 11:04 AM by Michael CroftPRINCETON, NJ - Mar 27, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced that it has acquired Ascendance Biotechnology, IncFull story -
WCG (WIRB-Copernicus Group) Clinical Services Division Acquires ACI Clinical Adjudication and Data Monitoring Safety Committees
Mar 27, 2018, 09:02 AM by Michael CroftPRINCETON, NJ - Mar 27, 2018 - WCG (WIRB-Copernicus Group®) Clinical Services Division, the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of ACI Clinical, the top provider of Endpoint Adjudication and Data Monitoring Safety CommitteesFull story -
Creative Enzymes Launches Insulin Degrading Enzyme for Bio-researchers
Mar 25, 2018, 21:23 PM by Michael CroftSHIRLEY, NY - Mar 26, 2018 - As an excellent supplier and manufacturer, Creative Enzymes recently launches insulin degrading enzyme, also known as insulysin or insulin protease, for researchers working in the life science fieldFull story